| abstract |
The present invention relates to 4-{[4-({[4-(2,2,2-trifluoroethoxy)-1,2-benzisoxazol-3-yl]oxy}methyl)piperidin A novel crystalline form of pyridin-1-yl]methyl}-tetrahydro-2H-pyran-4-carboxylic acid. More specifically, the present invention relates to polymorphic forms (polymorphic form I, polymorphic form II, polymorphic form III, polymorphic form IV, polymorphic form V, and polymorphic form VI) and the preparation of such polymorphic forms A method, a composition comprising the polymorphic forms, and the use of the polymorphic forms. |